Article Details

Neurana Pharmaceuticals Completes $60M Series A Financing

Retrieved on: 2018-05-06 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

Neurana Pharmaceuticals Completes $60M Series A Financing. View article details on hiswai:

Excerpt

<div>Neurana Pharmaceuticals, Inc., a San Diego, CA-based specialty pharmaceutical company focused on the treatment of neuromuscular conditions, completed a $60m Series A financing. The round was led by <b>Sofinnova Ventures</b> with participation from New Leaf Venture Partners, H.I.G. BioHealth ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up